Sterling Investment Advisors (Pennsylvania)’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-600	Closed	-$36K	–	207
2022 Q2	$36K	Hold	600	–	–	0.01%	256
2022 Q1	$38K	Hold	600	–	–	0.01%	283
2021 Q4	$45K	Buy	600 +200	+50%	+$15K	0.01%	265
2021 Q3	$45K	Hold	400	–	–	0.01%	260
2021 Q2	$65K	Buy	+400	New	+$65K	0.02%	233